Development and Validation of a Risk Tool for Predicting Severe Toxicity in Older Adults Receiving Chemotherapy for Early-Stage Breast Cancer

PURPOSE: Limited tools exist to predict the risk of chemotherapy toxicity in older adults with early-stage breast cancer. METHODS: Patients of age ≥ 65 years with stage I-III breast cancer from 16 institutions treated with neoadjuvant or adjuvant chemotherapy were prospectively evaluated for geriatr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Oncol
Autors principals: Magnuson, Allison, Sedrak, Mina S., Gross, Cary P., Tew, William P., Klepin, Heidi D., Wildes, Tanya M., Muss, Hyman B., Dotan, Efrat, Freedman, Rachel A., O'Connor, Tracey, Dale, William, Cohen, Harvey J., Katheria, Vani, Arsenyan, Anait, Levi, Abrahm, Kim, Heeyoung, Mohile, Supriya, Hurria, Arti, Sun, Can-Lan
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2021
Matèries:
ORIGINAL REPORTS
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8189621/
https://ncbi.nlm.nih.gov/pubmed/33444080
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.20.02063
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars